BIO 2017 International #1: CAR-T Therapies on Solid Tumors

CAR-T Therapies on Solid Tumors

Here is an excellent summary by BIOtechNow Editors on the application of CAR-T (Chimeric Antigen Receptor) T-Cell therapies on solid tumors. Up until now CAR-T shows great promise against blood cancers but challenges remain for solid tumors.

Here are some of the major companies engaged in CAR-T:

Bellicum Pharmaceuticals (BLCM), bluebird bio (BLUE), Cellectis SA (CLLS), Juno Therapeutics (JUNO), Kite Pharma (KITE). Poseida Therapeutics is a private Company.

 

Unleashing CAR-T Therapies on Solid Tumors: Are We There Yet?

 

, , ,

No comments yet.

Leave a Reply